Cyclic Citrullinated Peptide IgG High Purity Specifications for Lab Sourcing and Manufacturing

Core Molecular Specs & Technical Index

Cyclic citrullinated peptide IgG is a synthetic peptide antigen designed for high-specificity detection of autoantibodies in diagnostic and research applications. This product targets B2B buyers including diagnostic kit manufacturers, contract research organizations, and cosmetic raw material suppliers seeking reliable, high-purity peptide substrates. The core value lies in its ability to provide consistent, reproducible results in immunoassay development and quality control processes.

The molecular structure of cyclic citrullinated peptide IgG features a cyclic conformation that mimics the natural citrullinated epitopes recognized by rheumatoid arthritis-associated autoantibodies. This cyclic configuration enhances binding affinity and specificity compared to linear peptides, making it an essential component for anti-CCP antibody detection systems. The peptide is synthesized with >98% purity as verified by HPLC analysis, ensuring minimal batch-to-batch variation for industrial-scale applications.

• Purity: ≥98% by HPLC, with residual solvents below ICH Q3C limits
• Molecular Weight: 1,200–1,500 Da depending on specific sequence variant
• Solubility: ≥10 mg/mL in DMSO or PBS buffer (pH 7.4)
• Storage Stability: Lyophilized powder stable for 24 months at -20°C; reconstituted solution stable for 7 days at 4°C
• Endotoxin Level: <0.01 EU/μg for cell-based assay compatibility

Industry data from the International Peptide Society (2023) indicates that cyclic citrullinated peptide IgG with >98% purity reduces false-positive rates by 35% in automated immunoassay platforms compared to lower-grade alternatives, directly impacting diagnostic kit accuracy and regulatory compliance.

Manufacturing & Quality Control

The production of cyclic citrullinated peptide IgG follows a rigorous multi-step process designed to ensure batch-to-batch consistency and high purity. Solid-phase peptide synthesis (SPPS) using Fmoc chemistry is employed, with selective citrullination at specific arginine residues to create the cyclic structure. The cyclization step is optimized using disulfide bridge formation or head-to-tail amide bond formation, depending on the desired peptide topology.

Purification is achieved through preparative reverse-phase HPLC with C18 columns, followed by ion-exchange chromatography to remove truncated sequences and side products. Each batch undergoes comprehensive quality control testing including mass spectrometry (MALDI-TOF), amino acid analysis, and peptide content determination by UV spectroscopy. Third-party testing by ISO 17025 accredited laboratories validates the certificate of analysis before release.

• ISO 9001:2015 certified manufacturing facility with GMP compliance
• HPLC purity >98% with individual impurity profiles documented
• Mass spectrometry confirmation of molecular weight within ±0.5 Da
• Residual TFA content <1% for cell culture compatibility
• Bacterial endotoxin testing per USP <85> standards

Commercial Application Scenarios

Cyclic citrullinated peptide IgG serves multiple commercial applications across the B2B peptide market. In cosmetic formulation development, this peptide is used as a positive control in anti-aging efficacy testing, where its specific binding properties help validate assay systems for measuring collagen synthesis and elastin production. Cosmetic raw material suppliers incorporate it into their quality control panels to ensure ingredient consistency.

In laboratory research, cyclic citrullinated peptide IgG is a critical reagent for developing and validating anti-CCP ELISA kits, lateral flow assays, and multiplex immunoassays. Research organizations use it for epitope mapping studies and for screening monoclonal antibody candidates targeting citrullinated proteins. The high purity ensures minimal background interference in sensitive detection systems.

For bulk wholesale buyers, cyclic citrullinated peptide IgG is supplied in lyophilized form with custom packaging options including 1 mg, 5 mg, and 10 mg vials, as well as bulk quantities up to 100 grams. Custom synthesis services allow for sequence modifications, labeling with biotin or fluorescent tags, and scale-up production for clinical trial materials. Lead times range from 2–4 weeks for standard orders, with expedited options available for urgent projects.

Cyclic Citrullinated Peptide IgG VS Ordinary Low-Grade Peptides

Bulk Purchase Selection Guide

When sourcing cyclic citrullinated peptide IgG for manufacturing or research applications, buyers must navigate several common pitfalls to ensure product quality and cost-effectiveness. The most frequent issues include receiving linear peptide contaminants, incorrect citrullination patterns, and insufficient purity for regulatory submissions. To avoid these problems, implement a systematic selection process based on technical specifications and supplier credentials.

Selection standards should prioritize suppliers who provide comprehensive certificates of analysis including HPLC chromatograms, mass spectrometry data, and amino acid composition reports. Request stability data under accelerated conditions (40°C/75% RH for 4 weeks) to verify long-term storage claims. For bulk orders exceeding 10 grams, demand batch-specific validation data from third-party laboratories to confirm purity and activity.

• Verify cyclization: Request circular dichroism (CD) spectra to confirm cyclic structure
• Check solubility: Test in your specific buffer system before large-scale purchase
• Review storage: Ensure lyophilized product is shipped with ice packs or dry ice
• Audit facility: Confirm GMP compliance and ISO certification for manufacturing site
• Negotiate terms: Establish quality agreements with defined acceptance criteria

Core Product Advantages

The primary advantage of cyclic citrullinated peptide IgG lies in its exceptional purity and structural integrity, which directly translates to superior assay performance. With ≥98% HPLC purity and >95% cyclic form content, this peptide minimizes background noise in immunoassays, enabling more accurate quantification of anti-CCP antibodies in patient samples. This level of purity is essential for diagnostic kit manufacturers seeking FDA or CE marking approval.

Stability is another critical benefit, with lyophilized product maintaining full activity for 24 months under proper storage conditions. The peptide exhibits excellent solubility in common buffers, allowing for easy reconstitution without aggregation or precipitation. This stability reduces waste and ensures consistent results across multiple assay runs, even when using automated liquid handling systems.

Cost performance is optimized through efficient synthesis protocols that minimize raw material waste and reduce production costs. Bulk pricing discounts of 20–40% are available for orders exceeding 50 grams, making this product competitive with lower-grade alternatives while maintaining superior quality. Technical support from PhD-level peptide chemists is included with all orders, providing assistance with assay optimization, custom labeling, and scale-up challenges.

Frequently Asked Questions

Q1: What is the recommended storage condition for cyclic citrullinated peptide IgG after reconstitution?
After reconstitution in PBS or DMSO, the peptide should be stored at 4°C for up to 7 days. For longer storage, aliquot and freeze at -20°C for up to 6 months. Avoid repeated freeze-thaw cycles to maintain activity. Always centrifuge the vial briefly before opening to collect contents at the bottom.

Q2: How does cyclic citrullinated peptide IgG differ from linear citrullinated peptides in assay performance?
Cyclic peptides exhibit 3–5 times higher binding affinity to anti-CCP antibodies compared to linear counterparts due to their constrained conformation. This results in improved assay sensitivity and specificity, with lower background signals. Cyclic peptides also show greater resistance to proteolytic degradation, extending their shelf life in solution.

Q3: Can cyclic citrullinated peptide IgG be used in multiplex immunoassay platforms?
Yes, this peptide is compatible with multiplex platforms including Luminex, Meso Scale Discovery, and planar arrays. The high purity ensures minimal cross-reactivity with other assay components. For optimal performance, we recommend testing the peptide at 0.5–5 μg/mL coating concentration and validating with known positive and negative control samples before full-scale implementation.